Department of Laboratory Medicine, University of California San Francisco, USA.
Clin Toxicol (Phila). 2011 Apr;49(4):340-4. doi: 10.3109/15563650.2011.572556.
CONTEXT. Intralipid® infusion is useful in reversing cardiac and central nervous system toxicity of local anesthetic drugs, and recent reports suggest utility in other drug overdoses. CASE DETAILS. A 47-year-old man presented to the emergency department with hypotension and complete heart block 3 h after a sustained-release verapamil overdose. He was given supportive care including calcium and hyperinsulinemia/euglycemia therapy. Nineteen and 29 h post-ingestion, Intralipid® was administered as a bolus, followed by an infusion. OBJECTIVE. The objective of this study was to determine the serum verapamil concentrations before and after Intralipid® administration and to ascertain its clinical effects. DISCUSSION. It was found that administration of Intralipid® was followed by a decrease in verapamil concentration once the lipid had been removed from the sample, demonstrating that Intralipid® was effective in sequestering verapamil, effectively removing it from the serum, and supporting its use in the treatment of verapamil overdose. Intralipid® administration was associated with an increase in the patient's blood pressure, but because other vasoactive drugs were given at the same time, it was difficult to determine its relative contribution to clinical improvement.
脂肪乳剂输注可逆转局麻药的心脏和中枢神经系统毒性,近期有报道称其对其他药物过量也有效。
一名 47 岁男性,持续释放维拉帕米过量 3 小时后出现低血压和完全性心脏阻滞,被收入急诊。给予包括钙和高胰岛素血症/高血糖治疗在内的支持性治疗。摄入后 19 小时和 29 小时,给予脂肪乳剂推注,随后输注。
本研究旨在确定脂肪乳剂给药前后血清维拉帕米浓度,并确定其临床效果。
结果发现,一旦脂质从样本中去除,脂肪乳剂的给药就会导致维拉帕米浓度降低,表明脂肪乳剂能有效隔离维拉帕米,将其从血清中有效去除,支持其用于治疗维拉帕米过量。脂肪乳剂给药后患者血压升高,但由于同时给予了其他血管活性药物,因此难以确定其对临床改善的相对贡献。